VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NAMS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NAMSNewAmsterdam Pharma Company N.V.
$36.99$4.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNAMSPrice History

NAMS logoNewAmsterdam Pharma Company N.V. (NAMS) Stock Price History

Historical prices from 2021 to 2026

$36.99+2.09  (+5.99%)close Jul 7
Returns
1M
+19.5%
3M
+9.1%
YTD
+5.1%
1Y
+90.1%
3Y
+46.3%
5Y
+30.5%
ATH$42.20May 2026-12.4%
ATL$5.63Oct 2023pre-split
Avg Vol (50D)1.3M/ day
52-Week Range$19.28 — $42.20
LowCurrent: $36.99High

Loading 10-year price history...

NAMS Historical Performance

1 YearTotal Return
+90.1%
Price: +90.1%
3 YearsTotal Return
+212.9%
CAGR: +46.3%
Price: +212.9%
5 YearsTotal Return
+278.2%
CAGR: +30.5%
Price: +278.2%
YTD
+5.1%

NAMS Annual Returns

Year-by-year price performance · 2021–2026

Best+115.1%2024
Worst-8.1%2021
Up years4/6
2021-8.1%
2022+11.2%
2023-0.3%
2024+115.1%
2025+35.1%
2026+0.7%
2021 annual price return
-8.1%
2022 annual price return
+11.2%
2023 annual price return
-0.3%
2024 annual price return
+115.1%
2025 annual price return
+35.1%
2026 annual price return
+0.7%
LessMore
Alpha vs S&P 500
1Y+56.5%
3Y+17.7%
5Y+14.4%

Price returns only.

Download Historical Data

1,358 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

NAMS Stock Price Trajectory (2021–2026)

As of July 8, 2026, NewAmsterdam Pharma Company N.V. (NAMS) trades at $36.99, representing a +90.1% return over the past year. The stock has delivered a +278.2% total return over five years (+30.5% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $42.21 on May 11, 2026. From this peak, NAMS has corrected -12.4%, currently trading 10% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers ESPR (+184.7% 1Y), MDGL (+88.6% 1Y), and LNTH (+30.6% 1Y), NAMS has underperformed the peer group average. Compare NAMS vs ESPR →

NAMS Historical Price Data · from 2021

Rows 1–50 of 1,358
Date Open High Low Close Volume Change %
2026-07-0735.0337.1934.2736.99904K+5.99%
2026-07-0635.8335.8333.8334.90908K+0.20%
2026-07-0235.2736.3433.8734.831.19M-0.97%
2026-07-0134.3335.4034.0635.17856K+3.78%
2026-06-3034.5934.7333.5833.891.02M+0.06%
2026-06-2933.7434.0132.5933.871.15M+1.90%
2026-06-2631.5633.4131.5633.240+4.76%
2026-06-2532.4433.0931.7231.731.68M-2.76%
2026-06-2431.5533.0431.5032.631.22M+3.92%
2026-06-2330.5931.4930.3131.40995K+1.88%
2026-06-2230.1630.9529.7030.821.54M+3.32%
2026-06-1830.9631.1629.6429.831.23M-1.06%
2026-06-1730.2030.9129.7530.15929K-0.13%
2026-06-1630.5531.5529.0930.191.15M-1.34%
2026-06-1531.0331.4830.4530.60689K+0.66%
2026-06-1230.3731.5230.0130.40673K+0.46%
2026-06-1129.2330.4329.1330.262.03M+3.17%
2026-06-1030.1831.1329.3029.33854K-3.46%
2026-06-0931.4631.8629.6130.381.09M-1.84%
2026-06-0831.8632.6230.8130.95482K-1.81%
2026-06-0532.5533.2830.9131.521.08M-3.52%
2026-06-0432.1433.4232.1232.671.31M+1.74%
2026-06-0331.6932.4631.3332.111.03M+1.26%
2026-06-0231.6032.2430.7231.711.27M-0.25%
2026-06-0132.7133.2431.7231.791.20M-5.61%
2026-05-2935.4335.4333.2833.682.29M-4.91%
2026-05-2836.4236.7335.2235.42842K-3.12%
2026-05-2735.9937.3435.6736.56927K+1.25%
2026-05-2635.8836.2035.0036.11795K+1.89%
2026-05-2235.8635.8635.0135.44565K-0.73%
2026-05-2135.0636.4635.0035.701.04M-0.14%
2026-05-2034.8136.1934.0035.751.22M+6.02%
2026-05-1933.9734.1932.9633.721.81M-1.23%
2026-05-1835.9736.1333.4534.141.93M-3.67%
2026-05-1536.6336.6335.0835.441.10M-3.90%
2026-05-1437.6237.8036.4536.88952K-2.30%
2026-05-1338.3638.8736.9637.751.74M-2.93%
2026-05-1239.6339.7438.3238.892.14M-1.77%
2026-05-1137.6242.2037.6239.592.74M+2.22%
2026-05-0834.8541.1734.8538.734.73M+11.13%
2026-05-0733.0235.0531.1234.852.50M+12.46%
2026-05-0630.2231.0629.8630.991.04M+3.68%
2026-05-0529.9531.0029.1029.89880K+0.10%
2026-05-0428.2329.9028.0929.861.34M+5.03%
2026-05-0128.7429.1128.0328.431.38M-0.46%
2026-04-3029.1929.3128.3028.56571K+0.46%
2026-04-2928.4028.7127.9328.43610K-1.01%
2026-04-2830.4530.9627.8528.721.43M-5.68%
2026-04-2730.4531.3229.8430.451.24M+2.46%
2026-04-2431.5231.7529.5329.72933K-5.53%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NAMS — Frequently Asked Questions

Quick answers to the most common questions about buying NAMS stock.

How has NAMS stock performed recently?

NAMS returned +90.1% over the past year, beating its 5-year annualized CAGR of +30.5%. The stock trades above its 200-day moving average, confirming the uptrend.

What is NAMS's all-time high price?

NewAmsterdam Pharma Company N.V. reached $42.20 on 2026-05-11. The 52-week high is $42.20. Current 1-year return of +90.1% places the stock closer to historical peaks.

Where can I download NAMS historical price data?

This page provides NAMS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

454 data points · sampled from 1,358